Pulse Biosciences, Inc.
PLSE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001625101
In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Pulse Biosciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 57 | 2 | 72 | +17 |
| Shares | 4.83M | 1.19M | 5.61M | +1.97M (+54.0%) |
| Value | $54.1M | $13.3M | $98.4M | +$57.6M (+141.4%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Pulse Biosciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,347,685 | $23.6M | 0.00% |
| Swiss National Bank | 35,900 | $629.7K | 0.00% |
| Goldman Sachs Group Inc | 35,695 | $626.1K | 0.00% |
| UBS Asset Management Americas Inc | 33,535 | $588.2K | 0.00% |
| State of Wisconsin Investment Board | 24,059 | $422.0K | 0.00% |
| Franklin Resources Inc | 22,866 | $377.7K | 0.00% |
| Squarepoint Ops LLC | 16,227 | $284.6K | 0.00% |
| Engineers Gate Manager LP | 11,410 | $200.1K | 0.00% |
| Group One Trading, L.P. | 10,723 | $188.1K | 0.01% |
| Wealth Management Partners, LLC | 10,271 | $180.2K | 0.08% |
| STRS Ohio | 6,700 | $117.5K | 0.00% |
| Acadian Asset Management LLC | 1,536 | $26.0K | 0.00% |
| Darwin Advisors, LLC | 1,200 | $21.0K | 0.01% |
| Citadel Advisors LLC | 354 | $6.21K | 0.00% |
| US Bancorp | 105 | $1.84K | 0.00% |
| Aster Capital Management (DIFC) Ltd | 77 | $1.35K | 0.00% |
| GAMMA Investing LLC | 51 | $895 | 0.00% |
| Sterling Capital Management LLC | 19 | $333 | 0.00% |
| Capital Performance Advisors LLP | 4 | $70 | 0.00% |
| Covestor Ltd | 6 | $0 | 0.00% |
Sold out (3)
Institutions that held Pulse Biosciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Yakira Capital Management, Inc. | 11,313 | $126.6K |
| Price T Rowe Associates Inc | 10,787 | $121.0K |
| Simplex Trading, LLC | 465 | $5.00K |
Not filed for Q3 2024 yet (2)
Institutions that held Pulse Biosciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,146,873 | $12.8M |
| Spotlight Asset Group, Inc. | 40,290 | $450.8K |